send link to app

Home Vision Monitor® app for iPhone and iPad


4.2 ( 7552 ratings )
Health & Fitness Medical
Developer: Vital Art and Science, LLC
Free
Current version: 1.0.9, last update: 9 months ago
First release : 02 Feb 2021
App size: 91.33 Mb

Indication for Use:
The Home Vision Monitor is intended for the detection and characterization of the central 3 degrees metamorphopsia (visual distortion) in patients with maculopathy, including age-related macular degeneration and diabetic retinopathy, and as an aid in monitoring the progression of disease factors causing metamorphopsia. It is intended to be used by patients who have the capability to regularly perform a simple self-test at home. The Home Vision Monitor is not intended to diagnose; diagnosis is the responsibility of the prescribing eye care professional.

What is myVisionTrack® Home Vision Monitor?
The Home Vision Monitor uses an advanced “shape discrimination” vision test which has been proven accurate and effective for you to self-test your vision at home. Shape discrimination involves showing you multiple shapes, with only one being different to the others. The application allows you to quickly and accurately test your own vision to help monitor whether your vision is changing due to age-related macular disease or diabetes. During the test, you will be asked to select the shape that looks different compared to the others. Results of the test are stored, and automatically compared with your previous test results.

Home Vision Monitor is a personal monitor that should be used only by the individual to whom the application was prescribed. If someone else takes the test in your place, it could make your results inaccurate and mean that an important change in your vision is missed. To try the test without sending your test results, select "Demo" in the More Menu.

What happens if you post a user review on the app store?
If you post a user review, please note that your feedback will be shared with the device manufacturer and its representative in Europe to decide if a safety report should be made to a regulatory authority in the USA, the UK, or any other country.